Thereafter, NKX3-1 transcript levels of JURKAT and PER-117 were compared to that of the prostate cell line LNCAP, indicating about 9-fold higher expression in prostate cells than in T-ALL cells (Fig. 1C). This evidence concerns the gene NKX3-1 and acute lymphoblastic leukemia.